These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 11989476

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neuropsychological outcome of NTBC-treated patients with tyrosinaemia type 1.
    De Laet C, Munoz VT, Jaeken J, François B, Carton D, Sokal EM, Dan B, Goyens PJ.
    Dev Med Child Neurol; 2011 Oct; 53(10):962-4. PubMed ID: 21745202
    [No Abstract] [Full Text] [Related]

  • 3. Hepatomegaly: commentary.
    Rowe S, Pohl JF.
    Clin Pediatr (Phila); 2005 Oct; 44(9):814-6. PubMed ID: 16327972
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer?
    Koelink CJ, van Hasselt P, van der Ploeg A, van den Heuvel-Eibrink MM, Wijburg FA, Bijleveld CM, van Spronsen FJ.
    Mol Genet Metab; 2006 Dec; 89(4):310-5. PubMed ID: 17008115
    [Abstract] [Full Text] [Related]

  • 6. Nitisinone: new drug. Type 1 tyrosinemia: an effective drug.
    Prescrire Int; 2007 Apr; 16(88):56-8. PubMed ID: 17458044
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In brief: Nitisinone (Orfadin) for hereditary tyrosinemia.
    Med Lett Drugs Ther; 2016 Oct 10; 58(1505):e132. PubMed ID: 27701365
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Pharmacological and clinical profile of nitisinone (Orfadin(®) Capsules): a therapeutic agent for hereditary tyrosinemia type 1].
    Minoura H, Iwai M, Taniuchi Y, Katashima M, Takahashi H.
    Nihon Yakurigaku Zasshi; 2015 Dec 10; 146(6):342-8. PubMed ID: 26657126
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pregnancy in an NTBC-treated patient with hereditary tyrosinemia type I.
    Kassel R, Sprietsma L, Rudnick DA.
    J Pediatr Gastroenterol Nutr; 2015 Jan 10; 60(1):e5-7. PubMed ID: 23838819
    [No Abstract] [Full Text] [Related]

  • 13. Ophthalmic follow-up of patients with tyrosinaemia type I on NTBC.
    Gissen P, Preece MA, Willshaw HA, McKiernan PJ.
    J Inherit Metab Dis; 2003 Jan 10; 26(1):13-6. PubMed ID: 12872835
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nontransplant treatment of tyrosinemia.
    Holme E, Lindstedt S.
    Clin Liver Dis; 2000 Nov 10; 4(4):805-14. PubMed ID: 11232358
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.